CHELSEA PATTON: Open Payments
NPI 1487908364 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 35 payments from 13 companies in 2025. Trend: 2023 $747 · 2024 $850 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| Amgen Inc. | 3 | $61 |
| SCPHARMACEUTICALS INC. | 3 | $54 |
| AtriCure, Inc. | 1 | $54 |
| HEARTFLOW, INC. | 3 | $51 |
| Recor Medical Inc | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: LEQVIO, JARDIANCE, ELIQUIS, Kerendia, REPATHA, FUROSCIX, SYNERGY ABLATION SYSTEM, FFRct.
Industry payments across PA — which companies pay providers there.
